Establishment of N-succinimidyl 4-(maleimidomethyl) cyclohexanecarboxylate (SMCC) modified biochip enabling concurrent detection of serum infectious antibodies in neuroborreliosis
- 1 April 2016
- journal article
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 78, 404-410
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81171655)
- Anhui Province (1403062023)
This publication has 26 references indexed in Scilit:
- Lyme disease: A rigorous review of diagnostic criteria and treatmentJournal of Autoimmunity, 2015
- Invasive potential of Borrelia burgdorferi sensu stricto ospC type L strains increases the possible disease risk to humans in the regions of their distributionParasites & Vectors, 2014
- Peptide-Modified Surfaces for Enzyme ImmobilizationPLOS ONE, 2011
- Epidemiology of Lyme Borreliosis2009
- Validation of Cultivation and PCR Methods for Diagnosis of Lyme NeuroborreliosisJournal of Clinical Microbiology, 2008
- A Direct Immunoassay Assessment of Streptavidin- and N-Hydroxysuccinimide-Modified Biochips in Validation of Serological TNFα Responses in Hemophagocytic LymphohistiocytosisSLAS Discovery, 2008
- Advanced polymers for molecular recognition and sensing at the interfaceJournal of Chromatography B, 2008
- Antigen biochips verify and extend the scope of antibody detection in Lyme borreliosisDiagnostic Microbiology and Infectious Disease, 2007
- Guidelines for the diagnosis of tick-borne bacterial diseases in EuropeClinical Microbiology and Infection, 2004
- Cerebello‐thalamo‐cerebral projection from the dentate nucleus onto the frontal eye field in the catActa Physiologica Scandinavica, 1994